Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9288789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Expression of CD44 Variants in Differentiated Thyroid Cancers

  1996cited by this paper
• Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene

  1996cited by this paper
• The polymerase chain reaction: new variations on an old theme.

  1995cited by this paper
• Targeted gene therapy.

  1995cited by this paper
• Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation.

  1995cited by this paper
• Localization of oncofetal and normal fibronectin in colorectal cancer. Correlation with histologic grade, liver metastasis, and prognosis

  1995cited by this paper
• Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues

  1994cited by this paper
• Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3.

  1994cited by this paper
• Diagnosis of thyroid nodules by fine needle biopsy: use and abuse.

  1994cited by this paper
• Oncofetal fibronectins in oral carcinomas:

  1994cited by this paper
• PCR Amplification and Analysis of RAS Oncogenes from Thyroid Cytologic Smears

  1994cited by this paper
• The gene therapy of cancer: transgenic immunotherapy.

  1993cited by this paper
• Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach.

  1993cited by this paper
• Overexpression of p53 as a Possible Prognostic Factor in Human Thyroid Carcinoma

  1993cited by this paper
• The gene therapy of cancer : transgenic immunotherapy. Discussion

  1993cited by this paper
• Identification and analysis of the gene encoding human PC2, a prohormone convertase expressed in neuroendocrine tissues.

  1992cited by this paper
• Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

  1992cited by this paper
• Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma.

  1991cited by this paper
• Epidermal growth factor receptor and thyrotropin response in human thyroid tissues

  1990cited by this paper
• High Prevalence of Occult Papillary Thyroid Carcinoma in a Surgical Series for Benign Thyroid Disease

  1990cited by this paper
• Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections.

  1990cited by this paper
• Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue.

  1989cited by this paper
• The WHO histological classification of thyroid tumors: A commentary on the second edition

  1989cited by this paper
• Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

  1988cited by this paper
• The molecular basis of the sparse fur mouse mutation.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The complete structure of the rat thyroglobulin gene.

  1986cited by this paper
• The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.

  1985cited by this paper
• Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

  1985cited by this paper
• Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

  1985cited by this paper
• Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells

  1984cited by this paper
• Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer.

  1981cited by this paper
• Isolation of a major cell surface glycoprotein from fibroblasts.

  1974cited by this paper

• Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1

  2017cites this paper
• Molecular Classification of Thyroid Tumor: A Proposal Based on the Fetal Cell Carcinogenesis Hypothesis

  2015cites this paper
• Microarray technology to investigate genes associated with papillary thyroid carcinoma.

  2015cites this paper
• The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid

  2014cites this paper
• The Basic Theory of Fetal Cell Carcinogenesis of the Thyroid

  2014cites this paper
• An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma

  2014cites this paper
• Expression analysis of stemness genes in a rat thyroid cell line FRTL5.

  2014cites this paper
• Fetal cell carcinogenesis of the thyroid: a modified theory based on recent evidence.

  2014cites this paper
• Trefoil Factor 3 (TFF3) mRNA Expression Level in Follicular Thyroid Tumors Using Formalin-Fixed, Paraffin-Embedded (FFPE) Blocks

  2013cites this paper
• Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients

  2012cites this paper
• The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.

  2011cites this paper
• Gene expression profiles for radiation-induced thyroid cancer.

  2011cites this paper
• Application of immunohistochemistry to thyroid neoplasms.

  2009cites this paper
• Possible involvement of BRAFV600E in altered gene expression in papillary thyroid cancer.

  2009cites this paper
• Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.

  2009cites this paper
• [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].

  2007cites this paper
• Fetal cell carcinogenesis of the thyroid: theory and practice.

  2007cites this paper
• Cytological and histological diagnoses of recurrent thyroid carcinoma with monoclonal antibody JT-95, which can detect modified fibronectin.

  2007cites this paper
• Nódulos com diagnóstico de padrão folicular: marcadores biológicos são o futuro?

  2007cites this paper
• Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.

  2007cites this paper
• Screening of by Sequence Expression of Specific Changes in mRNAs in Thyroid Tumors Specific Differential Display: Decreased c-fos mRNA in Papillary Carcinoma

  2006cites this paper
• Tensin3 is a novel thyroid-specific gene.

  2006cites this paper
• Aspiration Biopsies of Oncofetal Fibronectin Messenger RNA in Fine-Needle Papillary Carcinomas by Reverse Transcription-PCR Detection Accurate and Objective Preoperative Diagnosis of Thyroid Updated

  2006cites this paper
• Gene Expression in Poorly Differentiated Papillary Thyroid Carcinomas

  2006cites this paper
• BASIC SCIENCE REVIEW

  2005cites this paper
• Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma

  2005cites this paper
• Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

  2005cites this paper
• Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma

  2005cites this paper
• Fetal Cell Carcinogenesis: A New Hypothesis for Better Understanding of Thyroid Carcinoma

  2005cites this paper
• Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma.

  2004cites this paper
• Gene Expression Profiling Identifies Platelet-Derived Growth Factor as a Diagnostic Molecular Marker for Papillary Thyroid Carcinoma

  2004cites this paper
• Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.

  2004cites this paper
• Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)‐like nuclear alterations express molecular markers of PTC

  2004cites this paper
• Molecular detection of thyroid cancer: an update

  2004cites this paper
• Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas.

  2003influential citation
• Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.

  2003cites this paper
• [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].

  2003cites this paper
• Detección de marcadores de malignidad en nódulos tiroideos por transcripción reversa y reacción en cadena de la polimerasa (RT-PCR)

  2003cites this paper
• Galectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens

  2003cites this paper
• Polymerase Chain Reaction in the Detection of Tumor Cells: New Approaches in Diagnosis and Follow-Up of Patients with Thyroid Cancer

  2002cites this paper
• Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis.

  2002cites this paper
• Differential expression of IgG Fc binding protein (FcgammaBP) in human normal thyroid tissue, thyroid adenomas and thyroid carcinomas.

  2002cites this paper
• Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.

  2002cites this paper
• Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis

  2001cites this paper
• Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

  2001cites this paper
• Fetal fibronectin: a new screening-marker for bladder cancer?

  2001cites this paper
• Expression of Oncofetal Fibronectin and Syndecan-1 mRNA in 18 Human Lung Cancer Cell Lines

  2001cites this paper
• Single strand mRNA differential display (SSDD) applied to the identification of serine/threonine phosphatases regulated during cerebellar development.

  2001cites this paper
• Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas.

  2000cites this paper
• Gene expression profiles in thyroid carcinomas

  2000cites this paper
• Medullary thyroid carcinoma: an accurate pre-operative diagnosis by reverse transcription-PCR.

  2000cites this paper
• Preoperative diagnosis of thyroid carcinomas by aspiration biopsy-reverse transcription-polymerase chain reaction (ABRP): a report of two cases.

  2000cites this paper
• Advances in Brief Preoperative Diagnosis of Thyroid Papillary and Anaplastic Carcinomas by Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction of Oncofetal Fibronectin Messenger RNA 1

  1999cites this paper
• Measurement of the Expression of Oncofetal Fibronectin mRNA in Thyroid Carcinomas by Competitive Reverse Transcription-Polymerase Chain Reaction

  1999cites this paper
• Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific‐differential display: Decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors

  1999cites this paper
• Fibronectin Messenger RNA Transcription-Polymerase Chain Reaction of Oncofetal Carcinomas by Real-Time Quantitative Reverse Preoperative Diagnosis of Thyroid Papillary and Anaplastic Updated Version

  1999cites this paper
• Advances in the pathogenesis and treatment of thyroid cancer.

  1999cites this paper
• Analysis of splice variants of the fibronectin gene in thyroid carcinomas by reverse transcription-polymerase chain reaction: Increased expression of oncofetal fibronectin mRNA in papillary carcinomas is not caused by the alternation in splicing

  1999cites this paper
• Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.

  1999cites this paper
• Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid

  1999cites this paper
• Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy.

  1999cites this paper
• Screening of specific changes in mRNAs in thyroid tumors by sequence specific differential display: decreased expression of c-fos mRNA in papillary carcinoma.

  1999cites this paper
• Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies.

  1998influential citation
• Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

  1998cites this paper
• Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

  1998cites this paper
• Molecular identification of the antigens recognized by monoclonal antibody JT95 specific for thyroid carcinomas.

  1998cites this paper